The levels of IL1RN is a factor influencing the onset of rheumatoid arthritis in non-alcoholic fatty liver disease

Int Immunopharmacol. 2024 Feb 15:128:111528. doi: 10.1016/j.intimp.2024.111528. Epub 2024 Jan 18.

Abstract

With the improvement of global dietary conditions, non-alcoholic fatty liver disease (NAFLD) has gradually become prevalent. As the number of NAFLD patients increases, the coexistence of diseases associated with it has come into focus. In this study, based on immune phenotypes, intercellular communication activities, and clinical manifestations of NAFLD patients, IL1RN was identified as a central pro-inflammatory factor. Subsequently, potential downstream biological pathways of IL1RN in liver tissues and various cell types were enriched to describe its functions. Transcription factors Nfkb1, Jun, and Sp1, significantly associated with these functions, were also enriched. Functional studies of IL1RN suggest its potential to trigger autoimmune diseases. Given this, Mendelian randomization analysis was used to explore the causal relationship between NAFLD and various autoimmune diseases, with IL1RN considered as an intermediary introduced into Mendelian randomization studies. The results indicate that IL1RN and its partially related proteins play a certain mediating role in the process of NAFLD inducing rheumatoid arthritis (RA). Finally, additional research results suggest that intrahepatic ALT levels may influence IL1RN levels, possibly through amino acid metabolism.

Keywords: IL1RN; Mendelian randomization; NAFLD; Rheumatoid arthritis.

MeSH terms

  • Arthritis, Rheumatoid* / genetics
  • Autoimmune Diseases*
  • Genome-Wide Association Study
  • Humans
  • Interleukin 1 Receptor Antagonist Protein / genetics
  • Non-alcoholic Fatty Liver Disease* / metabolism
  • Phenotype

Substances

  • IL1RN protein, human
  • Interleukin 1 Receptor Antagonist Protein